Viking Therapeutic (VKTX) Positive Early Data in X-ALD Adds New Future Catalyst - Raymond James

Go back to Viking Therapeutic (VKTX) Positive Early Data in X-ALD Adds New Future Catalyst - Raymond James
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 5.70 -0.06 (1.04%)
Previous Close $5.76    52 Week High $5.17 
Open $5.76    52 Week Low $0.94 
Day High $5.79    P/E N/A 
Day Low $5.60    EPS $0.00 
Volume 670,168